Muscle Spasticity
Research News and Information

Saturday, November 21, 2009

Infections related to intrathecal baclofen therapy in children and adults: frequency and risk factors.

30 Oct 2009 OBJECT: The purpose of this study was to determine the frequency of infection and to identify risk factors for infection in connection with the implantation of an intrathecal baclofen (ITB) pump. METHODS: This retrospective study included all ... Read more...

Botulinum toxin type A in the healing of a chronic buttock ulcer in a patient with spastic paraplegia after spinal cord injury.

30 Oct 2009 BACKGROUND: Pressure sores are a significant secondary complication in spinal cord injured patients. A new indication for botulinum toxin type A is described here, in treatment of recurrent muscular spasms that had hampered the healing of a chronic ... Read more...

Spasticity and bone density after a spinal cord injury.

30 Oct 2009 STUDY DESIGN: Descriptive, cross-sectional study. OBJECTIVE: To assess the relationship between spasticity and bone mineral density in the lower extremities in individuals with a motor complete spinal cord injury. METHODS: Eighteen individuals, ... Read more...

Latest indexed articles for 'Muscle Spasticity'

These are the very latest articles for this heading:

• Infections related to intrathecal baclofen therapy in children and adults: frequency and risk factors. 30 Oct 2009
• Botulinum toxin type A in the healing of a chronic buttock ulcer in a patient with spastic paraplegia after spinal cord injury. 30 Oct 2009
• Spasticity and bone density after a spinal cord injury. 30 Oct 2009
• Robot-mediated and clinical scales evaluation after upper limb botulinum toxin type A injection in children with hemiplegia. 30 Oct 2009
• Adults with cerebral palsy: a workshop to define the challenges of treating and preventing secondary musculoskeletal and neuromuscular complications in this rapidly growing population. 29 Sep 2009
• Effectiveness of sedation using nitrous oxide compared with enteral midazolam for botulinum toxin A injections in children. 29 Sep 2009
• Triple pelvic osteotomy in complex hip dysplasia seen in neuromuscular and teratologic conditions. 30 Aug 2009
• Letter to the editor on 'Safety of botulinum toxin type A among children with spasticity secondary to cerebral palsy: a systematic review of randomized clinical trials'. 30 Aug 2009
• Effect of baseline spastic hemiparesis on recovery of upper-limb function following botulinum toxin type A injections and postinjection therapy. 30 Aug 2009
• A preliminary assessment of the benefits of the addition of botulinum toxin a to a conventional therapy program on the function of people with longstanding stroke. 30 Aug 2009
• Assessment: botulinum neurotoxin for the treatment of spasticity (an evidence-based review). 30 Aug 2009
• Assessment: botulinum neurotoxin for the treatment of spasticity (an evidence-based review). 30 Aug 2009
• Effects of different dilutions of botulinum toxin type A treatment for children with cerebral palsy with spastic ankle plantarflexor: a randomized controlled trial. 30 Aug 2009
• Comment on "Evidence of increased motoneuron excitability in stroke patients without clinical spasticity". 10 Aug 2009
• Open-label pilot trial of levetiracetam for cramps and spasticity in patients with motor neuron disease. 30 Jul 2009
• New clinical and research trends in lower extremity management for ambulatory children with cerebral palsy. 30 Jul 2009
• Selective motor control in spastic cerebral palsy. 30 Jul 2009
• [Clinical observation on the treatment for intractable systremma by warming needling combined with cupping] 29 Jun 2009
• Neutralizing antibodies and secondary therapy failure after treatment with botulinum toxin type A: much ado about nothing? 29 Jun 2009
• Functional electrical stimulation-assisted cycling of patients with multiple sclerosis: biomechanical and functional outcome--a pilot study. 29 Jun 2009

See a longer list of these articles.

Technical information about 'Muscle Spasticity'

Definition: A form of muscle hypertonia associated with upper MOTOR NEURON DISEASE. Resistance to passive stretch of a spastic muscle results in minimal initial resistance (a "free interval") followed by an incremental increase in muscle tone. Tone increases in proportion to the velocity of stretch. Spasticity is usually accompanied by HYPERREFLEXIA and variable degrees of MUSCLE WEAKNESS. (From Adams et al., Principles of Neurology, 6th ed, p54)

Descriptor UI: D009128

Alternative terms: Muscle Spasticity; Spasticity, Muscle; Spastic; Clasp-Knife Spasticity; Clasp Knife Spasticity; Spasticity, Clasp-Knife;

Related Mesh Headings: Spasm;

Allowable Qualifiers: blood; cerebrospinal fluid; chemically induced; classification; complications; congenital; diagnosis; diet therapy; drug therapy; economics; embryology; enzymology; ethnology; etiology; genetics; history; immunology; metabolism; microbiology; mortality; nursing; epidemiology; parasitology; pathology; physiopathology; prevention & control; psychology; radiography; radionuclide imaging; radiotherapy; rehabilitation; surgery; therapy; urine; veterinary; ultrasonography; virology;

Tree Number: C05.651.512; C10.597.613.550.550; C23.888.592.608.550.550;

History Note: 1977

Technical Notes: skeletal muscle only; note category: not physiological; spastic paralysis: coord NIM with PARALYSIS (IM); spasticity in cerebral palsy: coord NIM with CEREBRAL PALSY only if musc spasticity is especially discussed